MDS sells clinical trial services unit to Ricerca Biosciences

02/10/2010 | Reuters

MDS on Wednesday announced that Ricerca Biosciences has agreed to acquire its clinical trial services business for $45 million and some minority equity interests. MDS said the sale of the unit will complete its divestitures plan and allow the company to focus on Nordion, its medical isotope business.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care